Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flat sales growth for Schering's contrast media

This article was originally published in Clinica

Executive Summary

German company Schering's contrast media sales rose only 1% to DM 1,203 million ($800 million) in the first nine months of 1996. Contrast media sales in the US, however, rose 60%. This is due to considerable volume growth of Ultravist and Magnevist, which is largely attributable to Schering's distribution agreement with Abbott (see Clinica No 711, p 11). The continued decline in sales of Iopamiron in Japan is due to exchange rate effects.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089574

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel